ABSTRACT
Type-2 bitter taste receptors (Tas2Rs) are a large family of G protein-coupled receptors that are expressed in the oral cavity and serve to detect substances with bitter tastes in foods and medicines. Recent evidence suggests that Tas2Rs are also expressed extraorally, including in immune cells. However, the role of Tas2Rs in immune cells remains controversial. Here, we demonstrate that Tas2R126, Tas2R135, and Tas2R143 are expressed in mouse neutrophils, but not in other immune cells such as macrophages or T and B lymphocytes. Treatment of bone marrow-derived neutrophils from wild-type mice with the Tas2R126/143 agonists arbutin and d-salicin led to enhanced C-X-C motif chemokine ligand 2 (CXCL2)-stimulated migration in vitro, but this response was not observed in neutrophils from Tas2r126/135/143-deficient mice. Enhancement of CXCL2-stimulated migration by Tas2R agonists was accompanied by increased phosphorylation of myosin light chain 2 (MLC2) and was blocked by pretreatment of neutrophils with inhibitors of Rho-associated coiled-coil-containing protein kinase (ROCK), but not by inhibitors of the small GTPase RhoA. Taken together, these results demonstrate that mouse neutrophils express functional Tas2R126/143 and suggest a role for Tas2R126/143-ROCK-MLC2-dependent signaling in the regulation of neutrophil migration.
Subject(s)
Neutrophils , Receptors, G-Protein-Coupled/metabolism , Animals , Cell Movement , Ligands , Mice , Receptors, G-Protein-Coupled/agonists , Receptors, G-Protein-Coupled/genetics , Signal Transduction , TasteABSTRACT
In the lymphatic vascular system, lymph nodes (LNs) play a pivotal role in filtering and removing lymph-borne substances. The filtering function of LNs involves resident macrophages tightly associated with unique lymphatic sinus structures. Moreover, an intermittently arranged LN in the lymphatic pathway is considered to cooperatively prevent lymph-borne substances from entering blood circulation. However, the functional significance of tissue microarchitecture, cellular composition, and individual LNs in the "LN chain" system is not fully understood. To explore the mechanistic and histo-anatomical significance of LNs as lymph fluid filters, we subcutaneously injected fluorescent tracers into mice and examined the details of lymphatic transport to the LNs qualitatively and quantitatively. Lymph-borne tracers were selectively accumulated in the MARCO+ subcapsular-medullary sinus border (SMB) region of the LN, in which reticular lymphatic endothelial cells and CD169+F4/80+ medullary sinus macrophages construct a dense meshwork of the physical barrier, forming the main body to capture the tracers. We also demonstrated stepwise filtration via the LN chain in the lymphatic basin, which prevented tracer leakage into the blood. Furthermore, inflammatory responses that induce the remodeling of LN tissue as well as the lymphatic pathway reinforce the overall filtering capacity of the lymphatic basin. Taken together, specialized tissue infrastructure in the LNs and their systematic orchestration constitute an integrated filtering system for lymphatic recirculation.
ABSTRACT
The migration status of T cells within the densely packed tissue environment of lymph nodes reflects the ongoing activation state of adaptive immune responses. Upon encountering antigen-presenting dendritic cells, actively migrating T cells that are specific to cognate antigens slow down and are eventually arrested on dendritic cells to form immunological synapses. This dynamic transition of T cell motility is a fundamental strategy for the efficient scanning of antigens, followed by obtaining the adequate activation signals. After receiving antigenic stimuli, T cells begin to proliferate, and the expression of immunoregulatory receptors (such as CTLA-4 and PD-1) is induced on their surface. Recent findings have revealed that these 'immune checkpoint' molecules control the activation as well as motility of T cells in various situations. Therefore, the outcome of tumor immunotherapy using checkpoint inhibitors is assumed to be closely related to the alteration of T cell motility, particularly in tumor-draining lymph nodes (TDLNs). In this review, we discuss the migration dynamics of T cells during their activation in TDLNs, and the roles of checkpoint molecules in T cell motility, to provide some insight into the effect of tumor immunotherapy via checkpoint blockade, in terms of T cell dynamics and the importance of TDLNs.
ABSTRACT
Immune responses to non-pathogenic yeasts induced within the draining lymph node remain to be understood. In this study, we have investigated the changes in lymphocytes and their activity in skin-draining lymph nodes in response to transdermally injected zymosan (component of the yeast cell wall). Zymosan elicited the transient increase of B cell number and activation status without affecting the capacity for proliferation. The increased B cell content in the regional lymph nodes was likely due to the reduction of B cell egress from the tissue and in part the increase of homing from the circulation. Zymosan also upregulated the inflammatory cytokines, such as IL-1ß, IL-6, IL-12, and IFNγ, regulatory cytokines IL-10 and TGFß, and lymphoid chemokine CXCL13. Among these, the expression of IL-12 and IL-10 was markedly high in B cells. Altogether, these findings demonstrate a unique B cell-associated response to non-pathogenic yeast component in the draining lymph nodes. This will provide insights into the clinical and healthcare applications of non-pathogenic beneficial microbes.
Subject(s)
B-Lymphocytes/immunology , Lymph Nodes/immunology , Skin/immunology , Administration, Cutaneous , Animals , B-Lymphocytes/drug effects , Cytokines/metabolism , Female , Interleukin-10/metabolism , Interleukin-12/metabolism , Lymph Nodes/drug effects , Lymph Nodes/physiology , Lymphocytes/immunology , Male , Mice , Mice, Inbred C57BL , Skin/drug effects , Zymosan/pharmacologyABSTRACT
Identifying the specific functional regulator of integrin family molecules in cancer cells is critical because they are directly involved in tumor invasion and metastasis. Here we report high expression of PLOD2 in oropharyngeal squamous cell carcinomas (SCCs) and its critical role as a stabilizer of integrin ß1, enabling integrin ß1 to initiate tumor invasion/metastasis. Integrin ß1 stabilized by PLOD2-mediated hydroxylation was recruited to the plasma membrane, its functional site, and accelerated tumor cell motility, leading to tumor metastasis in vivo, whereas loss of PLOD2 expression abrogated it. In accordance with molecular analysis, examination of oropharyngeal SCC tissues from patients corroborated PLOD2 expression associated with integrin ß1 at the invasive front of tumor nests. PLOD2 is thus implicated as the key regulator of integrin ß1 that prominently regulates tumor invasion and metastasis, and it provides important clues engendering novel therapeutics for these intractable cancers.
Subject(s)
Blister/diagnosis , Epidermolysis Bullosa/diagnosis , Membrane Proteins/genetics , Neoplasm Proteins/genetics , Periodontal Diseases/diagnosis , Photosensitivity Disorders/diagnosis , Biopsy , Blister/genetics , Blister/pathology , Epidermolysis Bullosa/genetics , Epidermolysis Bullosa/pathology , Exons/genetics , Female , Humans , Microscopy, Electron , Periodontal Diseases/genetics , Periodontal Diseases/pathology , Photosensitivity Disorders/genetics , Photosensitivity Disorders/pathology , Skin/pathology , Skin/ultrastructure , Young AdultABSTRACT
Organized tissue structure in the secondary lymphoid organs (SLOs) tightly depends on the development of fibroblastic stromal cells (FSCs) of mesenchymal origin; however, the mechanisms of this relationship are poorly understood. In this study, we specifically inactivated the canonical NF-κB pathway in FSCs in vivo by conditionally inducing IκBα mutant in a Ccl19-IκBSR mouse system in which NF-κB activity is likely to be suppressed in fetal FSC progenitors. Given that NF-κB activation in fetal FSCs is essential for SLO development, the animals were expected to lack SLOs. However, all SLOs were preserved in Ccl19-IκBSR mice. Instead, the T cell area was severely disturbed by the lack of CCL21-expressing FSCs, whereas the follicles and associated FSC networks were formed. Fate mapping revealed that IκBSR-expressing cells constituted only a small fraction of stromal compartment outside the follicles. Taken together, our findings indicate an essential role of the canonical NF-κB pathway activity in the development of three FSC subsets common to SLOs and suggest transient or stochastic CCL19 expression in FSC progenitors and a compensatory differentiation program of follicular FSCs.
Subject(s)
Fibroblasts/physiology , Lymphoid Tissue/immunology , Mesenchymal Stem Cells/physiology , NF-kappa B/metabolism , T-Lymphocytes/physiology , Animals , Cell Differentiation , Cells, Cultured , Chemokine CCL19/genetics , Chemokine CCL19/metabolism , Chemokine CCL21/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , NF-KappaB Inhibitor alpha/genetics , NF-kappa B/genetics , Signal TransductionABSTRACT
The spatiotemporal regulation of immune responses in the lymph node (LN) depends on its sophisticated tissue architecture, consisting of several subcompartments supported by distinct fibroblastic stromal cells (FSCs). However, the intricate details of stromal structures and associated FSC subsets are not fully understood. Using several gene reporter mice, we sought to discover unrecognized stromal structures and FSCs in the LN. The four previously identified FSC subsets in the cortex are clearly distinguished by the expression pattern of reporters including PDGFRß, CCL21-ser, and CXCL12. Herein, we identified a unique FSC subset expressing both CCL21-ser and CXCL12 in the deep cortex periphery (DCP) that is characterized by preferential B cell localization. This subset was clearly different from CXCL12highLepRhigh FSCs in the medullary cord, which harbors plasma cells. B cell localization in the DCP was controlled chiefly by CCL21-ser and, to a lesser extent, CXCL12. Moreover, the optimal development of the DCP as well as medulla requires B cells. Together, our findings suggest the presence of a unique microenvironment in the cortex-medulla boundary and offer an advanced view of the multi-layered stromal framework constructed by distinct FSC subsets in the LN.
Subject(s)
B-Lymphocytes/immunology , Chemokine CCL21/immunology , Fibroblasts/immunology , Lymph Nodes/immunology , Receptor, Platelet-Derived Growth Factor beta/immunology , Animals , Chemokine CCL21/genetics , Fibroblasts/cytology , Lymph Nodes/cytology , Mice , Mice, Inbred BALB C , Mice, Nude , Mice, Transgenic , Receptor, Platelet-Derived Growth Factor beta/genetics , Stromal Cells/cytology , Stromal Cells/immunologyABSTRACT
Allogeneic organ transplants are rejected by the recipient immune system within several days or weeks. However, the rejection process of allogeneic T (allo-T) cells is poorly understood. In this study, using fluorescence-based monitoring and two-photon live imaging in mouse adoptive transfer system, we visualized the fate of allo-T cells in the in vivo environment and showed rapid elimination in secondary lymphoid organs (SLOs). Although i.v. transferred allo-T cells efficiently entered host SLOs, including lymph nodes and the spleen, â¼70% of the cells had disappeared within 24 h. At early time points, allo-T cells robustly migrated in the T cell area, whereas after 8 h, the numbers of arrested cells and cell fragments were dramatically elevated. Apoptotic breakdown of allo-T cells released a large amount of cell debris, which was efficiently phagocytosed and cleared by CD8+ dendritic cells. Rapid elimination of allo-T cells was also observed in nu/nu recipients. Depletion of NK cells abrogated allo-T cell reduction only in a specific combination of donor and recipient genetic backgrounds. In addition, F1 hybrid transfer experiments showed that allo-T cell killing was independent of the missing-self signature typically recognized by NK cells. These suggest the presence of a unique and previously uncharacterized modality of allorecognition by the host immune system. Taken together, our findings reveal an extremely efficient and dynamic process of allogeneic lymphocyte elimination in SLOs, which could not be recapitulated in vitro and is distinct from the rejection of solid organ and bone marrow transplants.
Subject(s)
Lymphocytes/immunology , T-Lymphocytes/immunology , Adoptive Transfer/methods , Animals , Apoptosis/immunology , Bone Marrow/immunology , Dendritic Cells/immunology , Female , Graft Rejection/immunology , Killer Cells, Natural/immunology , Lymph Nodes/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Mice, Nude , Spleen/immunologyABSTRACT
Lymphadenopathy is a frequently observed symptom in systemic lupus erythematosus, although the immunological role of lymph nodes (LNs) in systemic autoimmunity remains largely unknown. Here, we performed comprehensive and systematic analyses of LNs in lupus-prone NZB × NZW F1 (BWF1) mice, demonstrating extensive tissue re-organization of the systemic LNs with follicular expansion, hyper germinal center (GC) formation, atrophy of the paracortical T-cell area and expansion of the medulla in aged BWF1 mice bearing glomerulonephritis. The proportion of B cells was significantly increased in these reactive LNs but not in the spleen, and lymphocyte subsets involved in antibody production, i.e. GC B cells, follicular helper T cells and plasma cells, were elevated. Draining LNs of the affected organs, such as the renal and cervical nodes, showed enhanced tissue re-organization and accumulation of effector lymphocytes, suggesting the presence of a positive feedback loop of regional responses. LN cells isolated from disease-bearing animals produced anti-DNA antibody, indicating activation of autoreactive lymphocytes in situ. The substantial development of disease and LN alterations in mice that received a splenectomy at a young age points to the importance of other secondary lymphoid organs, most likely LNs, for the progression of autoimmune responses independent of the spleen. Taken together, our findings highlight the value of taking LN alterations and activities into consideration for understanding the pathogenesis of systemic autoimmunity.
Subject(s)
Aging/immunology , Germinal Center/pathology , Glomerulonephritis/immunology , Lupus Erythematosus, Systemic/immunology , Lymph Nodes/immunology , Animals , Antibodies, Antinuclear/blood , Autoimmunity , Cellular Microenvironment , Disease Models, Animal , Disease Susceptibility , Humans , Mice , Mice, Inbred NZB , Self ToleranceABSTRACT
Ras GTPase-activating proteins negatively regulate the Ras/Erk signaling pathway, thereby playing crucial roles in the proliferation, function, and development of various types of cells. In this study, we identified a novel Ras GTPase-activating proteins protein, RASAL3, which is predominantly expressed in cells of hematopoietic lineages, including NKT, B, and T cells. We established systemic RASAL3-deficient mice, and the mice exhibited a severe decrease in NKT cells in the liver at 8 weeks of age. The treatment of RASAL3-deficient mice with α-GalCer, a specific agonist for NKT cells, induced liver damage, but the level was less severe than that in RASAL3-competent mice, and the attenuated liver damage was accompanied by a reduced production of interleukin-4 and interferon-γ from NKT cells. RASAL3-deficient NKT cells treated with α-GalCer in vitro presented augmented Erk phosphorylation, suggesting that there is dysregulated Ras signaling in the NKT cells of RASAL3-deficient mice. Taken together, these results suggest that RASAL3 plays an important role in the expansion and functions of NKT cells in the liver by negatively regulating Ras/Erk signaling, and might be a therapeutic target for NKT-associated diseases.
Subject(s)
Natural Killer T-Cells/immunology , ras GTPase-Activating Proteins/immunology , Animals , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cell Line, Tumor , Galactosylceramides/administration & dosage , Galactosylceramides/immunology , Gene Knockdown Techniques , Humans , Interferon-gamma/biosynthesis , Interleukin-4/biosynthesis , Jurkat Cells , Liver/immunology , Liver/injuries , Liver/metabolism , Lymphocyte Function-Associated Antigen-1/metabolism , MAP Kinase Signaling System/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Natural Killer T-Cells/cytology , Natural Killer T-Cells/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, CXCR/metabolism , Receptors, CXCR6 , Signal Transduction/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , ras GTPase-Activating Proteins/deficiency , ras GTPase-Activating Proteins/geneticsABSTRACT
In order to further examine the reactivity of autoantibodies, mice were infected with a non-lethal strain of Plasmodium yoelii. Parasitemia appeared between days 10 and 21. During this period, hyperglycemia and hypothermia were serially obeserved and this phenomenon resembled stress-associated responses. In parallel with parasitemia, autoantibodies appeared against nucleus and double-stranded DNA in the sera. To examine further the reactivity of autoantibodies against tissues, immunohistochemical staining using sera from mice with or without malaria was conducted. Autoantibodies contained reactivity to erythrocytes in the spleen, bone marrow and peripheral blood, especially against tissues obtained from mice with malaria. In the liver and intestine, autoantibodies reacted with hepatocytes and intestinal epithelial cells, respectively. These results suggested that the reactivity of autoantibodies against erythrocytes and hepatocytes might be associated with the modulation of the disease course in malaria.
Subject(s)
Autoantibodies/immunology , Erythrocytes/immunology , Hepatocytes/immunology , Malaria/immunology , Plasmodium yoelii/immunology , Animals , Antibodies, Antinuclear/blood , Antibodies, Antinuclear/immunology , Antigens, Protozoan/immunology , Autoantibodies/blood , Hyperglycemia , Hypothermia , Intestinal Mucosa/cytology , Intestinal Mucosa/immunology , Liver/cytology , Liver/immunology , Mice , Mice, Inbred C57BL , Parasitemia/blood , Parasitemia/immunology , Spleen/immunologyABSTRACT
Capillary vessel flow in the base of the fingernail can be observed by microscopy. This flow is switched off under some conditions, such as coldness, surprise, and anger and is switched on again under other conditions, such as warming, relaxation, and mild exercise. In other words, capillary vessels perform two functions: switching flow on and off. It is speculated that the switch-off function is necessary to direct energy production to the glycolysis pathway, while the switch-on function is necessary for the mitochondrial pathway. This is because glycolysis takes place under anaerobic conditions, while oxidative phosphorylation in the mitochondria proceeds under aerobic conditions in the body. To switch off circulation, the negative electric charges on the surface of erythrocytes and the capillary wall may be decreased by stimulation of the sympathetic nerves and secretion of steroid hormones. Negative charge usually acts as repulsive force between erythrocytes and between erythrocytes and the capillary wall. By decreasing the negative charge, erythrocytes can aggregate and also adhere to the capillary wall. These behaviors may be related to the capillary flow switch-off function. Here, it is emphasized that the capillary vessels possess not only a switch-on function but also a switch-off function for circulation.
Subject(s)
Capillaries/physiology , Energy Metabolism , Glycolysis , Mitochondria/metabolism , HumansABSTRACT
Macrophages are the major source of the chemokines macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine (KC), which play a major role in neutrophil migration to sites of inflammation. Although extracellular ATP from inflammatory tissues induces several immune responses in macrophages, it is unclear whether ATP-stimulated macrophages affect neutrophil migration. Therefore, the aim of the present study was to investigate the role of ATP-induced MIP-2 production by macrophages. When ATP was injected intraperitoneally into mice, the number of neutrophils within the peritoneal cavity markedly increased, along with the levels of MIP-2 and KC in the peritoneal lavage fluid. Consistent with this, ATP induced MIP-2 production, but not that of KC, by peritoneal exudate macrophages (PEMs) in vitro. This occurred via interactions with the P2X(7) receptor and P2Y(2) receptor. Furthermore, treatment of PEMs with ATP led to the production of reactive oxygen species. The ATP-induced MIP-2 production was inhibited by treatment with the antioxidant N-acetyl-l-cysteine. Also, MIP-2 production was inhibited by pre-incubating PEMs with inhibitors of extracellular signal-regulated kinase 1/2 or p38 mitogen-activated protein kinase. The MIP-2 neutralization reduced the increase in neutrophil numbers observed in ATP-treated mice. Taken together, these results suggest that increased production of reactive oxygen species by ATP-stimulated macrophages activates the signalling pathways that promote MIP-2 production which, in turn, induces neutrophil migration.
Subject(s)
Adenosine Triphosphate/pharmacology , Chemokine CXCL2/metabolism , Chemotaxis, Leukocyte , Macrophages, Peritoneal/metabolism , Neutrophils/immunology , Acetylcysteine/pharmacology , Animals , Cell Movement , Cells, Cultured , Chemokines/metabolism , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Macrophages, Peritoneal/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neutrophils/metabolism , Reactive Oxygen Species/metabolism , Receptors, Purinergic P2X7/metabolism , Receptors, Purinergic P2Y2/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitorsABSTRACT
Natural killer (NK) T cells are well known to play important roles in both tumor rejection and the defense against infectious. Therefore, the antitumor potential of NKT cell-activating antigens have been the focus for the development of NKT cell-based immunotherapies. Up to now, several studies have revealed that the administrations of glycolipids (e.g. α-galactosylceramide) can successfully treat certain metastatic tumors. However, liver injuries appeared upon the application of these antigens. We previously examined the potential of using ß-glucosylceramide (ß-GlcCer) to inhibit tumor metastasis to the liver. The aim of this study was to determine the antimetastatic effects of ß-GlcCer and its impact on the activation of NKT cells. Intraperitoneal administration of ß-GlcCer enhanced the production of interferon-γ from hepatic lymphocytes containing NKT cells, and increased the cytotoxicity of hepatic lymphocytes against tumor cells. Moreover, ß-GlcCer administration suppressed the hepatic metastasis of tumors in wild type (WT) mice, but not in CD1d (-/-) or Jα18 (-/-) mice. The drawback associated with the other glycolipids in liver injury was not noted in WT mice treated with the continuous daily administration of ß-GlcCer for 2 weeks. The present study demonstrated that ß-GlcCer treatment activates invariant NKT cells, thus resulting in the inhibition of tumor metastasis.
Subject(s)
Antineoplastic Agents/administration & dosage , Glucosylceramides/administration & dosage , Immunologic Factors/administration & dosage , Liver Neoplasms/prevention & control , Lymphoma/prevention & control , Natural Killer T-Cells/physiology , Alanine Transaminase/blood , Animals , Antigens, CD/metabolism , Antigens, Differentiation, T-Lymphocyte/metabolism , Aspartate Aminotransferases/blood , Cell Line, Tumor , Cytotoxicity, Immunologic/drug effects , Gene Expression , Immunotherapy , Injections, Intraperitoneal , Interferon-gamma/blood , Interferon-gamma/genetics , Interferon-gamma/metabolism , Lectins, C-Type/metabolism , Liver/pathology , Liver Neoplasms/blood , Liver Neoplasms/secondary , Lymphoma/blood , Lymphoma/pathology , Mice , Mice, Inbred C57BL , Natural Killer T-Cells/drug effects , Natural Killer T-Cells/metabolism , Tumor Burden/drug effects , Xenograft Model Antitumor AssaysABSTRACT
Wild-type (WT) and CD1d(-/-) [without natural killer (NK) T cells] mice were treated with zymosan A to induce granuloma formation in the liver. Increased granuloma formation was seen in NKT-less mice on days 7 and 14 after administration. WT mice showed limited granuloma formation, and zymosan A eventually induced NKT cell accumulation as identified by their surface marker (e.g. CD1d-tetramer). Zymosan A augmented the expression of Toll-like receptor 2 on the cell surface of both macrophages and NKT cells. One possible reason for accelerated granuloma formation in NKT-less mice was increased production of interferon- γ (IFN-γ); a theory that was confirmed using IFN-γ(-/-) mice. Also, zymosan A increased interleukin-10 production in WT mice, which suppresses IFN-γ production. Taken together, these results suggest that NKT cells in the liver have the potential to suppress zymosan A-mediated granuloma formation.
Subject(s)
Cytoplasmic Vesicles/immunology , Interferon-gamma/immunology , Interleukin-10/immunology , Liver/immunology , Natural Killer T-Cells/immunology , Zymosan/immunology , Animals , Antigens, CD1d/immunology , Interferon-gamma/biosynthesis , Interferon-gamma/deficiency , Kinetics , Macrophages/immunology , Mice , Mice, Knockout , Toll-Like Receptor 2/immunologyABSTRACT
Natural killer T (NKT) cells are known to be specifically activated by α-galactosylceramide (α-GalCer) via their interaction with CD1d. At that time, NKT cells mediate autoreactivity and eventually induce hepatic injury. As these immune responses resemble acute autoimmune hepatitis, it was examined whether autoantibody production and the activation of autoantibody-producing B-1 cells were accompanied by this phenomenon. Autoantibodies against Hep-2 cells and double-stranded DNA were detected in sera as early as day 3 (showing a peak at day 14) when mice were treated with α-GalCer. On day 3, B220(low) cells appeared in the liver. These B220(low) cells were CD5(-) (i.e. B-1b cells) and CD69(+) (an activation marker). Primarily, such B220(low) cells were present in the peritoneal cavity, but the proportion of B220(low) cells increased with the administration of α-GalCer even at this site. In parallel with the appearance of B220(low) cells in the liver, hepatic lymphocytes acquired the potential to produce autoantibodies in in vitro cell culture in the presence of lipopolysaccharide. These results suggested that hepatic injury induced by α-GalCer administration resembled acute autoimmune hepatitis and that the major effector lymphocytes were NKT cells with autoreactivity and autoantibody-producing B-1 cells.
Subject(s)
Autoantibodies/immunology , B-Lymphocytes/immunology , Chemical and Drug Induced Liver Injury/immunology , Galactosylceramides/toxicity , Natural Killer T-Cells/immunology , Animals , Autoantibodies/biosynthesis , Autoantigens/immunology , B-Lymphocyte Subsets/immunology , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Galactosylceramides/immunology , Lymphocyte Activation/immunology , Mice , Mice, Inbred C57BLABSTRACT
Mice with malaria showed unique immunological responses, including the expansion of NK1.1(-)TCR(int) cells (extrathymic T cells). Since TCR(int) cells with autoreactivity and autoantibody-producing B cells (B-1 cells) are often simultaneously activated under autoimmune conditions, it was examined whether B-1 cells were activated in the course of malarial infection. From days 14 after infection, B220(low) B-1 cells appeared in the liver and spleen. The number of B220(low) B cells was highest at day 14, but the ratio was highest at days 28-35. In parallel with the appearance of B220(low) cells, autoantibodies against HEp-2 cells and double-stranded DNA were detected in sera. These B220(low) cells had phenotypes of CD44(high), CD23(-) and CD62L(-). In sharp contrast, conventional B220(high) B cells (B-2 cells) were CD44(low), CD23(+) and CD62L(+). These results suggested that malaria immune responses were not mediated by conventional T and B cells but resembled the responses during autoimmune diseases.
Subject(s)
Antibodies, Antinuclear/metabolism , B-Lymphocyte Subsets/metabolism , B-Lymphocytes/metabolism , Malaria/immunology , Plasmodium/immunology , Animals , Antigens, CD/biosynthesis , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/parasitology , B-Lymphocyte Subsets/pathology , B-Lymphocytes/immunology , B-Lymphocytes/parasitology , B-Lymphocytes/pathology , Hep G2 Cells , Humans , Leukocyte Common Antigens/biosynthesis , Liver/metabolism , Liver/pathology , Malaria/pathology , Malaria/physiopathology , Mice , Mice, Inbred C57BL , Parasitemia , Plasmodium/pathogenicity , Spleen/pathology , Transaminases/metabolismABSTRACT
Severe hepatic injury is induced by Concanavalin A (Con A) administration in mice, the major effector cells being CD4(+) T cells, NKT cells and macrophages. Since autologous lymphocyte subsets are associated with tissue damage, Con A-induced hepatic injury is considered to be autoimmune hepatitis. However, it has remained to be investigated how autoantibodies and B-1 cells are responsible for this phenomenon. In this study, it was demonstrated that autoantibodies which were detected using Hep-2 cells in immunofluorescence tests and using double-strand (ds) DNA in the ELISA method, appeared after Con A administration (a peak at day 14). Moreover, autoantibody-producing B220(low) cells (i.e., B-1 cells) also appeared at this time. Purified B220(low) cells were found to have a potential to produce autoantibodies. These results suggest that Con A-induced hepatic injury indeed includes the mechanism of autoimmune hepatitis.
Subject(s)
Autoantibodies/immunology , B-Lymphocytes/immunology , Hepatitis, Animal/immunology , Natural Killer T-Cells/immunology , Alanine Transaminase/blood , Animals , Autoantibodies/blood , B-Lymphocytes/cytology , Cell Line, Tumor , Concanavalin A , Enzyme-Linked Immunosorbent Assay , Female , Granulocytes/cytology , Granulocytes/immunology , Hepatitis, Animal/blood , Hepatitis, Animal/chemically induced , Humans , Immunohistochemistry , Lymphocyte Count , Macrophages/cytology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Natural Killer T-Cells/cytology , Spleen/cytology , Spleen/immunology , Time FactorsABSTRACT
It is still controversial whether malaria protection is mediated by conventional immunity associated with T and B cells or by innate immunity associated with extrathymic T cells and autoantibody-producing B cells. Given this situation, it is important to examine the mechanism of malaria protection in beta(2)-microglobulin-deficient (beta(2)m(-/-)) mice. These mice lack major histocompatibility complex class I and CD1d antigens, which results in the absence of CD8(+) T cells and natural killer T (NKT) cells. When C57BL/6 and beta(2)m(-/-) mice were injected with parasitized (Plasmodium yoelii 17XNL) erythrocytes, both survived from the infection and showed a similar level of parasitaemia. The major expanding T cells were NK1.1(-) alphabeta T-cell receptor(int) cells in both mice. The difference was a compensatory expansion of NK and gammadelta T cells in beta(2)m(-/-) mice, and an elimination experiment showed that these lymphocytes were critical for protection in these mice. These results suggest that malaria protection might be events of the innate immunity associated with multiple subsets with autoreactivity. CD8(+) T and NKT cells may be partially related to this protection.